Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
39 studies found for:    " August 24, 2011":" September 23, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  Efficiency of the Hepatitis B Sci-B-Vac Vaccine in HIV Positive Patients
Condition: HIV
Intervention: Biological: Sci-B-Vac
2 Recruiting Safety and Immunogenicity of HIVAX in HIV-1 Infected Subjects
Condition: HIV Infections
Interventions: Biological: HIVAX;   Biological: saline solution;   Biological: Saline solution
3 Active, not recruiting Vitamin D Supplementation in HIV
Condition: HIV-infection/Aids
Interventions: Dietary Supplement: Vitamin D3;   Dietary Supplement: Placebo
4 Recruiting Study to Evaluate Safety and Toxicity of Polyphenon E (EGCG) in HIV-1-Infected Individuals
Condition: HIV Infection
Intervention: Drug: Polyphenon E
5 Completed Evaluating the Safety of and Immune Response to the VSV-Indiana HIV Vaccine in Healthy, HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: VSV-Indiana HIV gag vaccine;   Biological: Placebo injection (normal saline)
6 Active, not recruiting Study of Late Boost Strategies for HIV-uninfected Participants From Protocol RV 144
Condition: HIV Infections
Interventions: Biological: ALVAC-HIV;   Biological: AIDSVAX B/E;   Biological: ALVAC-HIV Placebo;   Biological: AIDSVAX B/E Placebo
7 Completed Evaluating the Safety and Immune Response to an HIV Vaccine Boost Following the Administration of Two HIV Vaccines, in HIV-Uninfected, Healthy Adults (Study Extension to HVTN 073/SAAVI 102)
Condition: HIV Infections
Interventions: Biological: Sub C gp140 Vaccine;   Biological: MF59C.1 Adjuvant;   Other: Sodium chloride
8 Completed
Has Results
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Interventions: Drug: COBI;   Drug: DRV;   Drug: NRTIs
9 Completed Safety Study of Maraviroc's Effect on Human Osteoclasts
Conditions: HIV Infections;   AIDS
Intervention: Drug: Maraviroc
10 Recruiting Implementation of Nucleic Acid Amplification Testing Screening to Identify Acute and Early HIV Infection
Condition: Acute HIV Infection
Intervention: Other: Nucleic Acid Amplification Testing
11 Completed Improving Uptake of Early Infant Diagnosis of HIV for the Prevention of Mother-to-child Transmission of HIV
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome
Intervention: Other: Text message
12 Completed
Has Results
A Key Link for Transmission Prevention
Condition: HIV
Interventions: Behavioral: Standard HIV prevention messages;   Behavioral: BI: Information-Motivation-Behavioral Skills Model;   Drug: Raltegravir;   Drug: emtricitabine/tenofovir disoproxil fumarate
13 Unknown  The Effect of Probiotics in HIV-1 Infection
Condition: HIV-1 Infection
Interventions: Dietary Supplement: Multi-strain probiotic;   Dietary Supplement: Placebo;   Other: Control
14 Completed Screening for Tuberculosis in HIV-infected Patients Eligible for Antiretroviral Treatment
Conditions: HIV Infection;   Tuberculosis
Intervention:
15 Unknown  Antiretroviral Treatment Strategies in Relation to Adherence, Resistance and Virological Treatment Failure
Condition: Human Immunodeficiency Virus (HIV)
Intervention: Behavioral: Enhanced Treatment Support (ETS)
16 Completed DRIVESHAFT: Darunavir/Ritonavir In HIV-infected Virologically-suppressed Experienced Subjects
Condition: HIV
Interventions: Drug: Twice-daily Darunavir/ritonavir;   Drug: Once-daily Darunavir/ritonavir
17 Terminated
Has Results
Efficacy of Neuro-HAART in Patients With HIV
Condition: HIV
Intervention:
18 Completed
Has Results
Potential for Drug-drug Interactions Between Boceprevir and Etravirine in HIV/Hepatitis C Virus Negative Volunteers
Conditions: Hepatitis C;   HIV
Intervention: Drug: boceprevir; etravirine
19 Completed Cohort Field Study to Assess the Safety and Efficacy of the PrePex Device for Non-Surgical Circumcision When Performed by Nurses
Conditions: Male Circumcision;   HIV Prevention
Intervention: Device: PrePex™ device
20 Unknown  Drug Exposure Registry for GSK2248761, an Investigational NNRTI
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: GSK2248761

   Previous Page Studies Shown (1-20) Next Page (21-39) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.